Cultural Science & Medicine seventy two (2011) 1342e1350
Contents email lists available at ScienceDirect
Social Technology & Medicine
journal website: www.elsevier.com/locate/socscimed
The pharmaceutical organization and the ‘good work' of managing can certainly bodies Tasleem Juana Padamsee*
Department of Sociology, Kansas State University, 238 Townshend Hall, 1885 Neil Method Mall, Columbus, OH 43210, United States
a r capital t i c l electronic i d f o
Article background: Available online three or more March 2011 Keywords: Girls Gender Medicalization Pharmaceutical companies Health care Peri menopause Infertility Imitation
a w s t r a c capital t
Pharmaceutical companies are intricately intertwined with every part of contemporary medical reality, and in addition they increasingly drive the sociable process of medicalization in order to build and master markets for drugs and devices. Furthermore to funding the majority of scientific research, managing it to create an data base that favors their innovations, in addition to uencing the regulation of pharmaceutical drug drugs and devices, firms still dedicate substantial methods on direct attempts to shape the attitudes, composition, and prescribing behavior of physicians. This post sheds new light about our picture of the romantic relationship between the pharmaceutical drug industry and physicians by simply examining a novel form of physician-directed conversation produced by one particular prominent corporation. An interpretive, thematic examination of ORGYN e the unique, full-length magazine published by Organon Firm between 1990 and 2003 e discloses two overarching messages this communicated to physicians in that period. First, it offered a compelling picture of the " good work” obstetricians and doctors do, which involves enabling females of reproductive age to manage their male fertility through contraception and infecundity treatment, and providing indicator relief and preventive fare ts to older women by increasing compliance with hormone therapy regimes. Second, it included pharmaceutical technology in every element of the doctor's work, representing pharmaceutical companies as the physician's " natural partner”, and women sufferers as unaggressive, disempowered objects of medical practice. Through these regular messages, the print magazine ORGYN represented 1 important group of mechanisms by which a pharmaceutical drug corporation helped drive and sustain medicalization. The article ends with a concern of the significance of ORGYN's messages for companies, doctors, women sufferers, and the research of medicalization. Ó 2011 Elsevier Ltd. All legal rights reserved.
Launch Pharmaceutical businesses are intricately intertwined with every facet of contemporary medical reality. Coming from de ning diseases and funding clinical research to training doctors and leading their recommending habits, the pharmaceutical industry has carefully embedded itself in the technology, regulation, and practice of modern medicine. Although medicalization e the de nition and treatment of lifestyle problems, processes, or deviance in medical terms (Zola, 1972) e was formerly driven by health care careers and businesses, it is now increasingly driven by simply pro t-oriented corporations aiming to establish and dominate marketplaces for their prescription drugs and devices (Conrad, 2005). Existing research documents a number of routes in which pharmaceutical corporations drive the continuing process of medicalization. Due mainly to recent regulatory improvements that enable increased latitude for advertising pharmaceutical products (Moynihan & Cassels, 2005; Sismondo, * Tel.: þ1 614 247 mid 1970s; fax: þ1 614 292 6687. Email address: padamsee. [email protected] edu. 0277-9536/$ elizabeth see the front matter Ó 2011 Elsevier Ltd. Almost all rights appropriated. doi: twelve. 1016/j. socscimed. 2010. 10. 034
2008; Tiefer, 2000), many companies now target print out and television ads straight to consumers, ‘educating' potential individuals about medical conditions and offered treatments, and effectively changing their self-perceptions to better t the medicines...
References: Altman, L. (1997). Experts find bias in drug data. The New York Times, C1eC8. Arney, M., & Rafalovich, A. (2007). Incomplete syllogisms as tactics of medicalization: the case of direct-to-consumer promoting in popular magazines, 1997 to 2003. Qualitative Overall health Research, 17(1), 49e60. Ballard, K. G., Elston, Meters. A., & Gabe, M. (2009). Non-public and public ageing in the UK: the changeover through menopause. Current Sociology, 57(2), 269e290. Ballard, E. D., Huk, D. M., & Wadsworth, M. Elizabeth. J. (2001). The function of the menopause in could experiences with the ‘change of life'. Sociology of Well being & Condition, 23(4), 397e424. Becker, G., & Nachtigall, R. Deb. (1992). Anticipating medicalisation: the social production of infecundity as a disease. Sociology of Health & Illness, 14(4), 456e471. Bekelman, J., Li, Y., & Gross, C. (2003). Scope and effects of nancial con icts of interest in biomedical exploration: a systematic assessment. Journal of the American Medical Association, 289, 454e465. Bell, S. (1987). Changing ideas: the medicalization of menopause. Social Scientific research & Medicine, 26(6), 535e542. Bodenheimer, T. (2000). Apprehensive alliance: specialized medical investigators as well as the pharmaceutical market. The New Britain Journal of Medicine, 342(20), 1539e1544. Conrad, G. (2005). The shifting engines of medicalization. Journal of Health and Social Behavior, 46(1), 3e14.
T. T. Padamsee / Social Technology & Remedies 72 (2011) 1342e1350 Mans eld, G. K., & Voda, A. (1997). Woman-centered information on peri menopause for physicians: ndings from your midlife women's health survey. Healthcare for ladies International, 18(1), 55e72. Marco, C. A., Moskop, M. C., Solomon, R. C., Geiderman, J. M., & Larkin, G. L. (2006). Gifts to physicians from the pharmaceutical sector: an honest analysis. Annals of Unexpected emergency Medicine, 48(5), 513e521. McCrea, F. W. (1983). The politics of menopause: the " discovery” of a sobre ciency disease. Social Concerns, 31(1), 111e123. Metzl, M. M. (2005). Prozac for the couch: Recommending gender inside the era of wonder prescription drugs. Durham: Fight it out University Press. Morgen, S i9000. (2001). In to our own hands: The can certainly health movement in the United States, 1969e1990. New Brunswick: Rutgers School Press. Moynihan, R. (2005). The marketing of a disease: female lovemaking dysfunction. Uk Medical Log, 330, 192e194. Moynihan, L., & Cassels, A. (2005). Selling sickness: How the planet's biggest pharmaceutic companies are turning us all into patients. Ny: Nation Ebooks. Moynihan, Ur., Heath, I., & Holly, D. (2002). Selling sickness: the pharmaceutical drug industry and disease mongering. British Medical Journal, 324(7342), 886e891. Organon. (1999). Organon corporate website. Retrieved via. http://www.organon.com. Organon. (2008). Organon corporate internet site. Retrieved coming from. http://www.organon.com. Payer, L. (1992). Disease-Mongers: How doctors, medicine companies, and insurers are making you feel ill. New York: David Wiley & Sons, Incorporation. Relman, A. (2001). Distancing continuing medical education from pharmaceutical promoting. Journal from the American Medical Association, 285(15), 2009e2011. Rennie, D., & Bero, T. A. (1990). Throw it away, Sam: the controlled circulation periodicals. American Record of Roentgenology, 13, 31e35. Schonberg, M. A., Davis, R. B., & Wee, C. C. (2005). After the women's wellness initiative: decision making and trust of women acquiring hormone remedy. Women's Health concerns, 15, 187e195. Scritch eld, S. A. (1995). The social construction of infecundity: from personal matter to social concern. In J. Best (Ed. ), Images of problems: Typifying modern social concerns (2nd ed. ). (pp. 61e97) Hawthorne: Aldine de Gruyter. Silverman, M., & Lee, S. R. (1974). Pills, pro ts, and Politics. Berkeley: University of California Press. Sismondo, H. (2004). Pharmaceutic maneuvers. Cultural Studies of Science, 34(2), 149e159. Sismondo, S. (2008). How pharmaceutic industry funding affects trial outcomes: causal structures and responses. Cultural Science & Medicine, sixty six, 1909e1914. Sismondo, S. (2009). Ghosts inside the machine: publication planning in the medical sciences. Social Research of Research, 39(2), 171e198. Smith, M. C., & Visconti, T. A. (1968). Appeals found in prescription drug advertising. Clinic Pharmacy, 3(2), 5e13. Starr, P. (1982). The sociable transformation of yankee medicine. New York: Basic Books. Swanson, J. M. (1986). Analyzing info for groups and explanation. In Watts. C. Chenitz, & M. M. Swanson (Eds. ), From practice to grounded theory: Qualitative research in nursing. Menlo Park: Addison-Wesley. Tiefer, D. (2000). Sexology and the pharmaceutical industry: the threat of cooptation. The Journal of Sex Analysis, 37(3), 273e283. Tiefer, T. (2004). Sexual is not only a natural action, and other essays (2nd ed. ). Boulder: Westview Press. Tiefer, D. (2006). Girl sexual dysfunction: a case study of disease mongering and activist level of resistance. Public Collection of Science Medicine,. eleven April. Vertinsky, P. (1998). " Run, Jane, Run”: central tensions in the current debate about enhancing women's wellness through exercise. Women & Health, 27(4), 81e109. Voda, A., & Ashton, C. (2006). After effects from the Can certainly Health Study: a unsuccsefflull vindication to get feminists plus the resurrection of hormone remedies. Sex Jobs, 54(5e6), 401e411. Washburn, T. (2001). Excessive in uence: how the medicine industry's electricity goes unrestrained and so why the problem is prone to get worse. September. American Possibility, 13, 16e22, b. Wazana, A. (2000). Physicians and the pharmaceutical sector: is a gift ever only a gift. Diary of the American Medical Association, 283, 373e380. Wilson, R. A. (1968). Feminine permanently. New York: Meters. Evans and Company. Worcester, N., & Whatley, M. H. (1992). The providing of HRT: playing for the fear component. Feminist Review, 41, 1e26. Zola, My spouse and i. K. (1972). Medicine because an establishment of interpersonal control. Sociological Review, 20(4), 487e504.
Conrad, P. (2007). The medicalization of contemporary society: On the transformation of man conditions in to treatable disorders. Baltimore: The Johns Hopkins University Press. Conrad, L., & Schneider, J. W. (1980). Deviance and medicalization: From badness to sickness. St . Paillette: C. Versus. Mosby. Corbin, J., & Strauss, A. (1990). Grounded theory research: procedures, canons, and evaluative criteria. Qualitative Sociology, 13(1), 3e21. Coupland, J., & Williams, A. (2002). Con icting discourses, shifting ideologies: pharmaceutical, ‘alternative', and feminist emancipatory text messaging on the perimenopause. Discourse & Society, 13(4), 419e445. DeAngelis, C. (2000). Con ict of interest and the public trust. Diary of the American Medical Association, 284(17), 2237e2238. Derry, L. (2004). Human hormones, menopause, and heart disease: producing sense in the Women's Well being Initiative. Ladies Health Issues, 14(6), 212e219. Derry, P. (2008). Update about hormones, menopause, and heart disease: evaluating specialist responses to the Women's Well being Initiative. Healthcare for Women International, 29(7), 720e737. Dillaway, H. (2005). Menopause is the " good old”: women's thoughts about reproductive : aging. Male or female & Culture, 19(3), 398e417. Fishman, T. R., & Mamo, T. (2001). Can be in a disorder: a ethnical analysis of medical and pharmaceutic constructions of male and female sexual dysfunction. Women & Therapy, 24(1/2), 179e193. Foster, P. (1995). Women and the health care market: An unhealthy relationship? Buckinghamshire: Wide open University Press. Freidson, At the. (1970). Job of medicine: A study of the sociology of utilized knowledge. New york city: Dodd, Mead. Friedman, L. S., & Richter, At the. D. (2004). Relationship between con ict of interest and research benefits. Journal of General Inside Medicine, 19, 51e56. Glaser, B. G. (1978). Assumptive sensitivity: Improvements in the Methodology of Grounded Theory. Work Valley: Sociology Press. Greene, J. (2004). Attention to " Details”: social grace and the pharmaceutical Salesmen in postwar UNITED STATES. Social Studies of Technology, 34(2), 271e292. Greil, J., Slauson-Blevins, K., & McQuillan, J. (2010). The experience of infertility: a review of new literature. Sociology of Well being & Health issues, 32(1), 140e162. Gullette, M. M. (1994). Menopause while magic gun: discursive consolidation/ strategies for social combat. Talk, 17(1), 93e122. Haraway, G. (1991). Simians, cyborgs, and ladies: The reinvention of character. New York: Routledge. Harding, J. (1997). Systems at risk: sexual intercourse, surveillance and hormone alternative therapy. Within a. Petersen, & R. Bunton (Eds. ), Foucault, health insurance and medicine (pp. 134e150). New York: Routledge. Hartley, H. (2003). " Big Pharma” in our bedrooms: a great analysis of the medicalization of women's sexual related issues. Advances in Gender Analysis, 7, 89e129. Healy, M. (2004). Healthy diet the close: in uences on the connection with everyday nerve fibres. Social Studies of Technology, 34(2), 219e245. Hutcheon, T., & Hutcheon, M. (1987). Medical " mythologies”: a semiotic method of pharmaceutical advertising and marketing. Queen's Quarterly, 94(4), 904e916. Jenkins, G. L., & Inhorn, M. C. (2003). Reproduction removed awry: medical anthropological points of views. Social Science & Medication, 56, 1831e1836. Jutel, A. (2010). Mounting disease: the example of girl hypoactive sexual interest disorder. Social Science & Medicine, 75, 1084e1090. Klein, R., & Dumble, L. J. (1994). Disempowering midlife women: technology and politics of hormone replacement therapy. Women's Studies International Online community, 17(4), 327e343. Lakoff, A. (2004). The anxieties of globalization: antidepressant sales and economic crisis in Argentina. Interpersonal Studies of Science, 34(2), 247e269. Side of the road, C. (2007). Shyness: Just how normal habit became a sickness. Fresh Haven: Yale University Press. Lawton, N., Rose, H., McLeod, D., & Dowell, A. (2003). Changes in use of hormone replacement therapy following the report from the Women's Wellness Initiative: cross sectional study of users. British Medical Journal, 327(7419), 845e846. Lewis, J. (1993). Feminism, the menopause, and hormone substitute therapy. Feminist Review, 43, 38e56. Lexchin, J. (1990). Drug makers and medicine regulators: as well close for comfort. Research of the Canadian situation. Cultural Science & Medicine, 31(11), 1257e1263. Lexchin, J., & O'Donovan, O. (2010). Prohibiting or ‘managing' con ict of interest? An assessment policies and procedures in three Western drug legislation agencies. Social Science & Medicine, seventy, 643e647.